Obesity, diet and lifestyle - DiabetesontheNet

Look AHEAD: Intensive lifestyle intervention less effective in those with higher HbA1c

Research is needed to help develop interventions that are effective for those with higher HbA1c.

9 May 2024

Diabetes Distilled: Calcium supplementation in people with diabetes – is caution needed?

Increased cardiovascular risk observed in people with diabetes taking regular calcium supplements.

6 Mar 2024

Diabetes Distilled: Physical activity – how much is needed to optimise glycaemic control?

Do people with type 2 diabetes need more physical activity than is recommended for the general population?

6 Mar 2024

Diabetes Distilled: Type 2 diabetes remission associated with renal and cardiovascular benefits

33–55% lower rates of CKD and 40–49% lower rates of CVD observed in Look AHEAD participants who achieved remission.

6 Mar 2024

Latest news: Tirzepatide prefilled pen; remission and cardiorenal benefits; and low-energy diets in primary care

Stay abreast of the latest news that could impact diabetes nursing.

29 Feb 2024

Type 2 diabetes remission with low-energy diet

Intensive lifestyle intervention achieves remission in primary care setting

21 Feb 2024

Type 2 diabetes remission with low-energy diet

Intensive lifestyle intervention achieves remission in primary care setting.

21 Feb 2024

Tirzepatide to be available in prefilled injection pen

Marketing authorisation given for GIP/GLP-1 agonist as four-dose KwikPen.

8 Feb 2024

Diabetes remission provides lasting cardiorenal benefits

Look AHEAD: New analyses reveal additional remission benefits.

22 Jan 2024

Editorial: New opportunities to support those New Year’s resolutions

The New Year is the perfect time to engage people with new invitations to attend type 2 diabetes and other wellbeing services.

10 Jan 2024

Diabetes Distilled: MACE risk higher in newly diagnosed type 2 diabetes treated with lifestyle alone

Foregoing therapies to reduce glucose, lipids and BP immediately after diagnosis increases MACE risk even if target glycaemic control is achieved.

10 Jan 2024

Diabetes Distilled: “Twincretin” tirzepatide significantly SURPASSes comparator effects on glucose, weight and quality of life

Will this highly effective new agent change current treatment guidelines, especially with regard to glycaemic and weight loss targets?

10 Jan 2024

Interactive case study: Obesity and type 2 diabetes

Assessing and managing obesity in the context of type 2 diabetes.

7 Nov 2023

Journal club: Ideas for diabetes care – something borrowed, something blue

Discussion of recent notable papers: Evidence-based interventions for clinics and high-risk communities.

18 Sep 2023

Editorial: Little chance of a summer lull this year!

Jane Diggle asks how best to manage a growing number of queries from patients unable to source their GLP-1 receptor agonist therapy.

18 Sep 2023

Overview of the NHS Type 2 Diabetes Path to Remission Programme

What primary care needs to know about the NHS type 2 diabetes remission programme, plus tips on improving uptake.

18 Sep 2023

ADA 2023: “An explosion” of promising innovations for type 2 diabetes and obesity

The latest developments in pharmacotherapy for weight loss and glucose lowering, presented at the ADA Scientific Sessions.

18 Sep 2023

Diabetes Distilled: Treating obesity is no longer inSURMOUNTable

Up to 15% weight loss achieved with tirzepatide in people with type 2 diabetes and comorbid obesity.

18 Sep 2023